Covalent assembly of nanoparticles as a peptidase-degradable platform for molecular MRI. (2017)
Attributed to:
Novel targeted contrast agent for early detection of brain metastasis: from animal to patient stage 2
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/ncomms14254
PubMed Identifier: 28198362
Publication URI: http://europepmc.org/abstract/MED/28198362
Type: Journal Article/Review
Volume: 8
Parent Publication: Nature communications
ISSN: 2041-1723